Description CJC-1295 with DAC (Drug Affinity Complex) is a modified version of CJC-1295, a synthetic peptide that mimics the action of growth hormone-releasing hormone (GHRH). The addition of the DAC component enables the peptide to bind covalently to albumin in the bloodstream, dramatically extending its half-life—often up to 7–10 days—compared to the few minutes seen with native GHRH. This…
Description CJC-1295 is a tetrasubstituted peptide designed to mimic the action of growth hormone-releasing hormone (GHRH) while offering enhanced stability and prolonged half-life through binding to albumin via a Drug Affinity Complex (DAC). This modification allows for sustained elevation of endogenous GH and IGF-1 levels for up to a week following administration. Research has focused on CJC-1295’s potential to…
